THE HARVEY PRACTICE
18 KIRKWAY, BROADSTONECKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 306 | 361 | 84.8% | |
CKD 4 | 2008 | 378 | 452 | 83.6% | |
CKD 5 | 2009 | 48 | 60 | 80.0% | |
CKD 5 | 2010 | 5 | 5 | 100.0% | |
CKD 5 | 2011 | 6 | 6 | 100.0% | |
CKD 5 | 2012 | 4 | 5 | 80.0% | |
CKD 5 | 2013 | 2 | 2 | 100.0% | |
CKD003 | 2014 | 6 | 6 | 100.0% | |
CKD003 | 2015 | 12 | 13 | 92.3% | |
NM84 | 2016 | 10 | 14 | 71.4% | |
NM84 | 2017 | 9 | 13 | 69.2% | |
NM84 | 2018 | 5 | 7 | 71.4% | |
NM84 | 2019 | 11 | 17 | 64.7% | |
NM84 | 2020 | 14 | 20 | 70.0% | |
NM84 | 2022 | 22 | 25 | 88.0% | |
NM84 | 2023 | 31 | 38 | 81.6% |